Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Image-Guided Percutaneous Lipiodol-Pingyangmycin Suspension Injection Therapy for Sacral Chordoma

  • Huang, Dexiao (Department of Interventional Radiology, Nanfang Hospital, Southern Medical University) ;
  • Chen, Yong (Department of Interventional Radiology, Nanfang Hospital, Southern Medical University) ;
  • Zeng, Qingle (Department of Interventional Radiology, Nanfang Hospital, Southern Medical University) ;
  • Wu, Renhua (Department of Medical Imaging, the 2nd Affiliated Hospital, Medical College of Shantou University) ;
  • Li, Yanhao (Department of Interventional Radiology, Nanfang Hospital, Southern Medical University)
  • Received : 2013.02.15
  • Accepted : 2013.06.06
  • Published : 2013.09.01
⟨ Previous Next ⟩

Abstract

A 74-year-old man presented with a progressively worsening pain in sacrum and was diagnosed to have a sacral chordoma by biopsy in May, 2004. Percutaneous intratumoral injection with lipiodol-pingyangmycin suspension (LPS) was carried out under image guidance and repeated when the pain in sacrum recurred and the tumor increased. During a 6-year follow-up period, three sessions of this treatment were executed. CT imaging and Karnofsky Performance Score were used to evaluate the size of tumor and quality of life, respectively. The patient was free of pain after each procedure and had a high quality of life with a Karnofsky Performance Score above 80 points. The tumor lesion in sacral area was effectively controlled. No complications were observed. Percutaneous intratumoral injection with LPS under image guidance may be an effective and safe alternative for the patients with sacral chordoma.

Keywords

References

  1. Chen Y, Li YH, Zeng QL, Zhao JB, Zhu QH, Huang DX, et al. Percutaneous intratumoral injection of lipiodol and chemotherapeutic agents emulsion for primary liver cancer. Chin J Gen Surg 2009;24:992-995
  2. Yang H, Zhu L, Ebraheim NA, Liu J, Shapiro A, Castillo S, et al. Surgical treatment of sacral chordomas combined with transcatheter arterial embolization. J Spinal Disord Tech 2010;23:47-52 https://doi.org/10.1097/BSD.0b013e31819630ec
  3. Wagner TD, Kobayashi W, Dean S, Goldberg SI, Kirsch DG, Suit HD, et al. Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys 2009;73:259-266 https://doi.org/10.1016/j.ijrobp.2008.03.074
  4. Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M. Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res 2010;468:2939-2947 https://doi.org/10.1007/s11999-010-1472-8
  5. Osaka S, Kondoh O, Yoshida Y, Ryu J. Radical excision of malignant sacral tumors using a modified threadwire saw. J Surg Oncol 2006;93:312-317 https://doi.org/10.1002/jso.20346
  6. Baltsavias G, Valavanis A. Endovascular occlusion of a lacerated primitive trigeminal artery during surgical resection of clival chordoma. A case report. Interv Neuroradiol 2010;16:204-207
  7. Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 2009;34:2233-2239 https://doi.org/10.1097/BRS.0b013e3181b61b90
  8. Imai R, Kamada T, Sugahara S, Tsuji H, Tsujii H. Carbon ion radiotherapy for sacral chordoma. Br J Radiol 2011;84 Spec No 1:S48-S54 https://doi.org/10.1259/bjr/13783281
  9. Nakajo M, Ohkubo K, Fukukura Y, Nandate T, Nakajo M. Treatment of recurrent chordomas by percutaneous ethanol injection therapy and radiation therapy. Acta Radiol 2006;47:297-300 https://doi.org/10.1080/02841850600550724
  10. Anis N, Chawki N, Antoine K. Use of radio-frequency ablation for the palliative treatment of sacral chordoma. AJNR Am J Neuroradiol 2004;25:1589-1591
  11. Marchal F, Brunaud L, Bazin C, Boccacini H, Henrot P, Troufleau P, et al. Radiofrequency ablation in palliative supportive care: early clinical experience. Oncol Rep 2006;15:495-499
  12. Kurup AN, Woodrum DA, Morris JM, Atwell TD, Schmit GD, Welch TJ, et al. Cryoablation of recurrent sacrococcygeal tumors. J Vasc Interv Radiol 2012;23:1070-1075 https://doi.org/10.1016/j.jvir.2012.05.043
  13. Zeng QL, Li YH, Chen Y, He XF, Lu Wei, Zhao JB, et al. The experimental study of intra-arterial infusion of pingyangmycin lipiodol emulsion in rabbits. J Clin Radiol (Chin) 2000;19:376-379
  14. Kong WD, Li YH, Zeng QL, Chen Y, He XF. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells]. Di Yi Jun Yi Da Xue Xue Bao 2003;23:830-832, 836
  15. Zeng Q, Li Y, Chen Y, Ouyang Y, He X, Zhang H. Gigantic cavernous hemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multicenter study. Cardiovasc Intervent Radiol 2004;27:481-485
  16. Huang D, Chen Y, Zeng Q, Zhao J, Wu R, Wu X, et al. Transarterial embolization using pingyangmycin lipiodol emulsion and polyvinyl alcohol for the treatment of focal nodular hyperplasia of the liver. Hepatogastroenterology 2011;58:1736-1741
  17. Chen Y, Li Y, Zhu Q, Zeng Q, Zhao J, He X, et al. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol 2008;190:966-971 https://doi.org/10.2214/AJR.07.2851
  18. Wu HB, Lu GC. Adverse reaction of pingyangmycin. Chin J Clin Pharm 2001;10:53-55
  19. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 2000;88:2122-2134 https://doi.org/10.1002/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO;2-1
  20. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 1999;44:74-79; discussion 79-80 https://doi.org/10.1097/00006123-199901000-00041
  21. Hanna SA, Aston WJ, Briggs TW, Cannon SR, Saifuddin A. Sacral chordoma: can local recurrence after sacrectomy be predicted? Clin Orthop Relat Res 2008;466:2217-2223 https://doi.org/10.1007/s11999-008-0356-7
  22. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 1999;24:1639-1645 https://doi.org/10.1097/00007632-199908150-00004
  23. Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer 1999;85:878-883 https://doi.org/10.1002/(SICI)1097-0142(19990215)85:4<878::AID-CNCR15>3.0.CO;2-7
  24. Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 2006;29:572-574 https://doi.org/10.1159/000096283

Cited by

  1. TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma vol.96, pp.30, 2013, https://doi.org/10.1097/md.0000000000007650